LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,334,802 | +71.0% | 105,721 | +105.8% | 0.01% | +75.0% |
| Q2 2023 | $3,704,065 | +2.1% | 51,374 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $3,629,230 | +5.9% | 49,337 | -3.8% | 0.00% | 0.0% |
| Q4 2022 | $3,426,907 | +161.2% | 51,301 | +413.0% | 0.00% | +300.0% |
| Q2 2021 | $1,312,000 | -47.5% | 10,000 | -38.9% | 0.00% | -50.0% |
| Q1 2021 | $2,497,000 | -24.6% | 16,377 | -50.8% | 0.00% | -33.3% |
| Q4 2020 | $3,311,000 | -55.2% | 33,290 | -57.1% | 0.00% | -62.5% |
| Q3 2020 | $7,395,000 | -66.8% | 77,581 | -61.1% | 0.01% | -70.4% |
| Q2 2020 | $22,305,000 | +57.5% | 199,423 | +2.4% | 0.03% | +22.7% |
| Q1 2020 | $14,166,000 | +77.4% | 194,806 | +154.4% | 0.02% | +144.4% |
| Q4 2019 | $7,985,000 | +6.8% | 76,570 | +1.9% | 0.01% | +12.5% |
| Q3 2019 | $7,479,000 | -25.0% | 75,126 | -14.0% | 0.01% | -38.5% |
| Q2 2019 | $9,976,000 | +85.4% | 87,404 | +104.2% | 0.01% | +62.5% |
| Q1 2019 | $5,380,000 | -80.0% | 42,805 | -78.4% | 0.01% | -78.4% |
| Q4 2018 | $26,946,000 | +26.6% | 198,566 | +156.0% | 0.04% | +42.3% |
| Q3 2018 | $21,289,000 | -9.9% | 77,557 | -32.0% | 0.03% | -16.1% |
| Q2 2018 | $23,641,000 | +89.6% | 114,114 | +51.1% | 0.03% | +93.8% |
| Q1 2018 | $12,471,000 | +18.6% | 75,505 | -1.7% | 0.02% | +6.7% |
| Q4 2017 | $10,519,000 | +109.8% | 76,824 | +108.6% | 0.02% | +87.5% |
| Q3 2017 | $5,015,000 | +1375.0% | 36,832 | +1215.4% | 0.01% | +700.0% |
| Q2 2017 | $340,000 | +14.9% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $296,000 | -76.8% | 2,800 | -77.7% | 0.00% | -50.0% |
| Q4 2016 | $1,278,000 | -66.4% | 12,579 | -60.5% | 0.00% | -71.4% |
| Q2 2016 | $3,802,000 | +581.4% | 31,879 | +512.1% | 0.01% | +600.0% |
| Q1 2016 | $558,000 | -89.1% | 5,208 | -89.0% | 0.00% | -87.5% |
| Q4 2015 | $5,123,000 | +864.8% | 47,253 | +662.1% | 0.01% | +700.0% |
| Q3 2015 | $531,000 | -86.1% | 6,200 | -83.7% | 0.00% | -83.3% |
| Q2 2015 | $3,833,000 | +148.4% | 37,990 | +89.8% | 0.01% | +200.0% |
| Q1 2015 | $1,543,000 | -8.4% | 20,014 | -26.0% | 0.00% | 0.0% |
| Q2 2014 | $1,684,000 | -67.4% | 27,030 | -64.8% | 0.00% | -71.4% |
| Q1 2014 | $5,165,000 | +113.9% | 76,800 | +67.3% | 0.01% | +133.3% |
| Q4 2013 | $2,415,000 | -46.0% | 45,911 | -55.6% | 0.00% | -57.1% |
| Q3 2013 | $4,473,000 | +104.3% | 103,342 | +76.7% | 0.01% | +75.0% |
| Q2 2013 | $2,189,000 | – | 58,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |